Dr. Harry Gill
Gill Harinder Singh Harry, MD, PhD, is currently Clinical Associate Professor at the Department of Medicine, School of Clinical Medicine, the University of Hong Kong. He graduated in 2006 and joined Queen Mary Hospital in 2007. Dr. Gill completed his Haematology and Haematological Oncology training in 2014, followed by Haematopathology training from 2017 to 2019. He earned his PhD in 2019, focusing on the genomics of myeloproliferative neoplasms and became the First Fellow in Genetics and Genomics (Medicine) in 2023.
He has published extensively in esteemed peer-reviewed journals, including Blood, Blood Advances, Haematologica, British Journal of Haematology, Bone Marrow Transplantation, Annals of Oncology, Journal of Clinical Oncology, Cancer and Science Translational Medicine. He is one of the founding members and directors of the Asian Myeloid Working Group leading key regional studies on myeloid malignancies in Asia including the Asian MDS Genomics Registry, the APL Asian Consortium Study, and the Asian MPN Registry.